The trial, conducted in Australia and the United States, had entered 19,114 people from the community who were aged 70 years or older or at least 65 for participants in the US identifying as Black or Hispanic.
ASPREE’s aspirin recipients experienced 20 fewer ischemic strokes with the trade-off of 29 extra IC bleeding events, notes a report on the secondary analysis published July 26 in JAMA Network Open, with lead author Geoffrey C. Cloud, MB, BS, Monash University, Melbourne, Australia.
Zdroj: Daily Aspirin Challenged for Preventing First Strokes
